Abstract
Bone marrow mesenchymal stem cells (BMSCs) has been considered as a therapeutic strategy for acute liver injury (ALI). However, the insufficient homing of BMSCs in vivo limited their applications. Ultrasound targeted microbubble destruction (UTMD) has shown the potential in promoting the homing of stem cells into ischemic myocardium. We therefore explored whether UTMD could promote BMSCs' homing in ALI rat models and its corresponding therapeutic effect. Methods: Bone marrow mesenchymal stem cells (BMSCs) were obtained from the femurs and tibias of Sprague-Dawley (SD) rats. The characteristics of BMSCs including the proliferative viability, diversified differentiation ability and specific cell surface markers' expression were verified by flow cytometry. In order to find the appropriate ultrasound parameters, the normal rat liver was exposed to different intensity of ultrasound (1.0 W/cm2, 1.5 W/cm2, 2.0 W/cm2) with 300µl microbubbles, and the expression of tumor necrosis factor $a$ (TNF-a) and stromal cell-derived factor 1 (SDF-1) were detected at 24h post-treatment. The ALI models were established via a single intraperitoneal injection of D-galactose on 32 SD rats, which then were randomly assigned into four groups: Control, BMSCs, UTMD, and UTMD+BMSCs. After the BMSCs were stably transfected with a lentivirus for expressing green fluorescent protein (GFP), these cells were then injected through tail vein in a concentration of 2×106/ml. Forty-eight hours after the treatment, the protein expression levels of SDF-1, intercellular cell adhesion molecule1(ICAM-1), vascular cell adhesion molecule 1(VCAM-1 and monocyte chemotactic protein 1 (MCP-1) of exposed liver were analyzed, and the number of GFP-transfected BMSCs were observed as well. Serum alanine transaminase (ALT), aspartate transaminase (AST) and alkaline phosphatase (ALP) activities were tested after 48 h/72 h/168 h of treatment. The histology of liver was evaluated at 168h. Results: The isolated rat BMSCs demonstrated good proliferation, osteogenic and adipogenic differentiation and the expression of CD29+, CD90+, CD45-, CD11b/c-. After the application of UTMD, the expression level of SDF-1 and TNF-a on exposed liver was markedly higher in 2.0 W/cm2 group than in the 1.5 W/cm2 and 1.0 W/cm2 group ( $p$ $p$ <0.05), as well as the protein expression of SDF-1, ICAM-1, VCAM-1 and MCP-1 (p<0.01). The ALT, AST and ALP activities were much lower in UTMD+BMSCs group. The pathological features of liver injury were alleviated to a large extent in UTMD+BMSCs group. Conclusion: Through upregulation of adhesion molecular and cytokines, UTMD could enhance the homing of BMSCs in rat models of ALI and improve the function of acute injured liver.
Highlights
Bone marrow mesenchymal stem cells (BMSCs) can provide an additional source of therapeutic stem cells for regeneration of liver cells during acute liver injury (ALI)
Culture and identification of rat BMSCs The freshly isolated BMSCs were spherical in morphology
The results showed that stromal cell-derived factor 1 (SDF-1), a major mediator involved in the homing of BMSCs in the injured liver, was markedly upregulated after the application of Ultrasound-targeted microbubble destruction (UTMD)
Summary
Bone marrow mesenchymal stem cells (BMSCs) can provide an additional source of therapeutic stem cells for regeneration of liver cells during acute liver injury (ALI). Ultrasound-targeted microbubble destruction (UTMD) has been reported to promote the homing of transplanted stem cells into the ischemic myocardium. We investigated whether UTMD promotes the hepatic homing of BMSCs in ALI rats and evaluated the therapeutic effect. Numerous studies have shown that stem cells can be used as a hepatocyte regeneration source for repairing an injured liver [4, 5]. Bone marrow-derived mesenchymal stem cells (BMSCs) have demonstrated therapeutic potential in treating acute and chronic liver diseases [6]. The ability of BMSCs to home to targeted tissues has been shown to be unsatisfactory, compromising the therapeutic effects. Facilitation of BMSCs homing to target tissues represents a priority for utilizing BMSCs for regenerative medicine
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.